Fact Based List:
Top U.S. Life Science R&D Expenditures for Q1-Q3 2012
Submitted by Anonymous on Thu, 12/20/2012 - 14:20
- Pfizer - $5,734
- Merck & Co. - $5,945
- Johnson & Johnson - $5,334
- Lilly (Eli) & Co. - $3,815
- Abbott Laboratories - $3,181
- Bristol-Myers Squibb Co. - $2,822
- Amgen - $2,411
- Celgene - $1,251
- Medtronic (estimated) - $1,167
- Monsanto - $1,166
Notes: In millions
Source: Battelle/R&D Magazine
Source URL: http://www.battelle.org/docs/default-document-library/2013-R...
List Ratings: |
Lists You Might Also Be Interested In
- JAMA Network: 5 Reasons Why Nurses Leave Their Jobs
- Ten Strategic Considerations of the Supreme Court Upholding PPACA
- Mike Townsend: 11 Ideas For Healthcare Innovation
- 4 Factors Fueling Medical Implant Market in North America
- Journal of Medical Economics study: Rate of VTE-related readmissions for 6 primary discharge diagnoses
Login or register to post comments